EYEFILL® C. -US Viscoelastic Clinical Investigation

Inclusion Criteria:

- Any race

- Older than 21 years

- Cataract requiring cataract extraction in at least 1 eye

- Clear intraocular media other than cataract

- Able to provide written informed consent

- Able and willing to comply with required follow-up schedule

- Competent to understand the procedure and the actions asked of him/her as a research
subject

Exclusion Criteria:

- Monocular

- Ocular infection

- History of glaucoma, Ocular Hypertension (IOP > 21 mmHg) likely to require IOP
lowering medications, ocular condition requiring IOP lowering medication, condition
preventing reliable Goldmann applanation tonometry, known steroid responder

- Previous intraocular surgery in the operative eye

- Previous serious corneal disease or known endothelial cell loss / damage (in
operative eye)

- History of chronic or recurrent inflammatory eye disease (in operative eye)

- Evidence of retinal vascular disease (in operative eye)

- Uncontrolled diabetes or proliferative diabetic retinopathy

- Acute or chronic disease or illness that would increase the operative risk

- Allergy to anesthetics or other postoperative medications

- Known hypersensitivity to sodium hyaluronate or other components in viscoelastic

- Patient in any other clinical trial within the 30 days prior to the start of the
study